Insurance Status Is Related to Receipt of Therapy and Survival in Patients with Early-Stage Pancreatic Exocrine Carcinoma

Emily Boevers; Bradley D McDowell; Sarah L Mott; Anna M Button; Charles F Lynch

doi:10.1155/2017/4354592

Back

Insurance Status Is Related to Receipt of Therapy and Survival in Patients with Early-Stage Pancreatic Exocrine Carcinoma

Journal article

Open access

Peer reviewed

Insurance Status Is Related to Receipt of Therapy and Survival in Patients with Early-Stage Pancreatic Exocrine Carcinoma

Emily Boevers, Bradley D McDowell, Sarah L Mott, Anna M Button and Charles F Lynch

Journal of Cancer Epidemiology, Vol.2017, p.4354592

04/10/2017

DOI: 10.1155/2017/4354592

PMCID: PMC5402230

PMID: 28487737

Files and links (2)

pdf

Insurance Status Is Related to Receipt of Therapy and Survival in1.31 MBDownload View

Published (Version of record)CC BY V4.0, Open Access

url

https://doi.org/10.1155/2017/4354592View

Published (Version of record)Journal of Cancer Epidemiology Volume 2017, Article ID 4354592, 5 pages.

Abstract

<p>Objectives. The study objective was to determine how insurance status relates to treatment receipt and overall survival for patients with early-stage pancreatic exocrine carcinoma. Methods. SEER data were evaluated for 17,234 patients diagnosed with Stage I/II pancreatic exocrine carcinoma. Multivariate regression models controlled for personal characteristics to determine whether insurance status was independently associated with overall survival and receipt of radiation/surgery. Results. Odds of receiving radiation were 1.50 and 1.75 times higher for insured patients compared to Medicaid and uninsured patients, respectively (p < 0.01). Insured patients had 1.68 and 1.57 times increased odds of receiving surgery compared to Medicaid and uninsured patients (p < 0.01). Risk of death was 1.33 times greater (p < 0.01) in Medicaid patients compared to insured patients; when further adjusted for treatment, the risk of death was attenuated but remained significant (HR = 1.16, p < 0.01). Risk of death was 1.16 times higher for uninsured patients compared to insured patients (p = 0.02); when further adjusted for treatment, the risk of death was no longer significant (HR = 1.01, p = 0.83). Conclusions. Uninsured and Medicaid-insured patients experience lower treatment rates compared to patients who have other insurances. The increased likelihood of treatment appears to explain the insured group's survival advantage.</p>

Medicine and Health Sciences

OAfund

uninsured patients

Medicaid

health insurnace

SEER data

cancer

pancreatic exocrine carcinoma

Details

Title: Subtitle: Insurance Status Is Related to Receipt of Therapy and Survival in Patients with Early-Stage Pancreatic Exocrine Carcinoma
Creators: Emily Boevers - University of Iowa
Bradley D McDowell - University of Iowa
Sarah L Mott - University of Iowa
Anna M Button - University of Iowa
Charles F Lynch - University of Iowa
Resource Type: Journal article
Publication Details: Journal of Cancer Epidemiology, Vol.2017, p.4354592
DOI: 10.1155/2017/4354592
PMID: 28487737
PMCID: PMC5402230
NLM abbreviation: J Cancer Epidemiol
ISSN: 1687-8558
Grant note: Funder: Holden Comprehensive Cancer Center Population Research Core and Biostatistics Core, Grant ID: P30 CA086862
Comment: This paper was presented in part at the Academic Surgical Congress, February 2015, Las Vegas, NV.
Language: English
Date published: 04/10/2017
Academic Unit: Epidemiology; Obstetrics and Gynecology; Holden Comprehensive Cancer Center
Record Identifier: 9983557429902771

Metrics

115 File views/ downloads

23 Record Views

16 Times Cited - Web of Science